The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Ulf Gerdtham. Photo.

Ulf Gerdtham

Professor

Ulf Gerdtham. Photo.

Economic Evaluation of Interventions for Screening of Dementia

Author

  • Sanjib Saha
  • Ulf-Göran Gerdtham
  • Håkan Toresson
  • Lennart Minthon
  • Johan Jarl

Summary, in English

OBJECTIVE: The objective is to systematically review the literature on economic evaluations of screening interventions for early diagnosis of dementia disorders. METHODS: A systematic search of published economic evaluation studies in English was conducted using specified key words in relevant databased and websites. Data extracted included methods and empirical evidence (costs, effects, incremental cost-effectiveness ratio) and we assessed if the conclusions made in terms of cost-effectiveness were supported by the reported evidence. The included studies were also assessed for reporting quality using the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist. RESULTS: Fourteen studies were identified and broadly fell into two groups: screening without biomarkers and screening using biomarkers. There was a considerable heterogeneity in methodological approaches, target populations, study time frames, and perspectives as well as types of biomarkers used. The sensitivity and specificity of screening instruments are one of the important aspects in estimating the cost-effectiveness of the interventions. Cost-effectiveness of non-biomarker based interventions cannot be judged due to lack of information. The biomarkers based screening have the potential to be cost-effective but their effectiveness has to be established first. CONCLUSION: More economic evaluations studies as well as good quality effectiveness studies are required in screening strategies before these can be implemented in the clinical practice.

Department/s

  • Health Economics
  • Department of Economics
  • Centre for Economic Demography
  • EpiHealth: Epidemiology for Health
  • MultiPark: Multidisciplinary research focused on Parkinson´s disease
  • Clinical Memory Research

Publishing year

2018-09-04

Language

English

Publication/Series

Working Papers

Issue

2018:20

Document type

Working paper

Topic

  • Economics

Keywords

  • Dementia, Screening, early diagnostic, economic evaluation
  • Dementia
  • Screening
  • Early diagnostic
  • Economic evaluation
  • H43
  • I10
  • I18

Status

Published

Research group

  • Health Economics
  • Clinical Memory Research